Bullish SYK thesis by danielcharts

SYK - Stryker Corp - Healthcare

SYK has been on a wild ride this past year. It hit above 400 just last summer, then basically trended down for months, with some nasty dips, especially this spring. That last leg down from around 340 in April to sub 300 in May was rough. Seeing it now hover around 316, it feels like a lot of the panic is probably in the price. Not exactly the timing anyone dreams of, but here we are.

I’m leaning bullish from here. Stryker still has a solid pipeline, especially with elective procedures and hospital CapEx starting to pick back up. The company’s execution has always stood out, and the demographic tailwind isn’t going away joint replacements and robotics are still long term growth drivers. If hospital budgets are normalizing (and recent management commentary suggested as much), their end markets could start looking a lot less soft over the next couple quarters.

I’m targeting 372.00 over the next 8 weeks. That lines up with the upper range of where it traded a few months ago, before the selloff got vicious. It’s not a hail mary moonshot, just a retrace to a more reasonable multiple if you figure growth picks back up. To get there, I’m expecting at least one solid earnings print or upbeat guidance to break this dead money trend.

The risk is pretty obvious: if hospital spending disappoints, or Stryker guides down again, the stock can easily retest the lows. Plus, if margin pressure shows up in the next report, you’re back in the penalty box. Not pretending there’s no risk, just think the risk/reward makes sense here with most of the recent pain already priced in.

Bullish

Open

Created May 26, 2026

Community vote

Entry Price

$316.48

Above

$372.00

Target Date

Jul 21, 2026

Karma

125 to 17562

Above target (win)Projection

Comments

May 27, 2026 · 13:29

Stryker’s pipeline is solid but man that last dump from 340 was ugly. Feels like buying after a bar fight. I’ll admit if elective procedures actually pick up, maybe you get your 372, but this thing’s got PTSD from the last few months. Not the smoothest dip buy but respect for stepping in.

May 31, 2026 · 14:06

I get the logic on “panic in the price” but the medtech space always gets extra jumpy if hospitals start delaying procedures again. Stryker’s pipeline isn’t magic if volumes stay meh. I’d wait for at least one solid quarter of recovery before calling bottom, honestly. At 316 it’s not a screaming deal if macro stuff goes sideways again.

May 31, 2026 · 14:53

but waiting for the “safe quarter” is how people end up buying back in at 370. I get that hospital delays suck, but you think every hospital in America just stops knee replacements forever? At 316, feels like the future bad news is already baked in, now it’s just a matter of how much FOMO kicks in on a green earnings print.

May 31, 2026 · 23:35

Honestly I get the logic of “panic is priced in” but I’m still nervous about catching a falling knife here. The pipeline is good, yeah, but if hospital budgets stay tight or procedures keep getting pushed, things could get choppy again. Stryker’s bounced before, but I’m not sure the bottom’s actually in. Probably smart to size this one carefully if you’re going long.

Jun 3, 2026 · 14:49

I hear you it’s not exactly a hero entry when SYK just cratered 40 bucks in a month. The pipeline’s good, true, but hospital capex is still a big wild card. I’d be more confident if we saw some stabilization in volumes before jumping in, honestly. Could just as easily see another leg down if Q2 stays ugly.

Jun 1, 2026 · 22:32

I’m with you on not loving the timing here. The 340 to sub 300 drop shook me up too. If procedures actually recover like you’re banking on, SYK probably does fine, but I don’t know if I buy that “panic is all priced in” until we see a real bounce in hospital spending. Tempting, but still feels a bit early for me.

Jun 1, 2026 · 23:08

I get it, the market’s not exactly screaming “bottom’s in” after that ugly drop, but you’re right that at 316 a whole lot of fear is probably baked in already. No one’s calling the perfect turn here, but if Stryker’s pipeline actually delivers and the elective stuff normalizes even a bit, it’s hard to see this sub 300 mess sticking. Hospital budgets are a legit risk though, so not loading up the truck personally, just keeping an eye on volume trends and guidance.